The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis

被引:150
|
作者
Kump, P. [1 ,2 ]
Wurm, P. [2 ,3 ]
Groechenig, H. P. [4 ]
Wenzl, H. [1 ]
Petritsch, W. [1 ]
Halwachs, B. [2 ,3 ,5 ]
Wagner, M. [1 ]
Stadlbauer, V. [1 ]
Eherer, A. [1 ]
Hoffmann, K. M. [6 ]
Deutschmann, A. [6 ]
Reicht, G. [7 ]
Reiter, L. [7 ]
Slawitsch, P. [7 ]
Gorkiewicz, G. [2 ,3 ,5 ]
Hoegenauer, C. [1 ,2 ,5 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria
[2] Med Univ Graz, Theodor Escherich Lab Med Microbiome Res, Graz, Austria
[3] Med Univ Graz, Inst Pathol, Graz, Austria
[4] Barmherzige Bruder Hosp, St Veit An Der Glan, Austria
[5] Interuniv Cooperat, BioTechMed Graz, Graz, Austria
[6] Med Univ Graz, Dept Pediat & Adolescent Med, Graz, Austria
[7] Barmherzige Bruder Hosp, Graz, Austria
基金
奥地利科学基金会;
关键词
EVIDENCE-BASED CONSENSUS; RNA GENE DATABASE; COMBINATION THERAPY; MAINTENANCE; REMISSION; COLONIZATION; METAANALYSIS; MANAGEMENT; INDUCTION; DIAGNOSIS;
D O I
10.1111/apt.14387
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundFaecal microbiota transplantation is an experimental approach for the treatment of patients with ulcerative colitis. Although there is growing evidence that faecal microbiota transplantation is effective in this disease, factors affecting its response are unknown. AimsTo establish a faecal microbiota transplantation treatment protocol in ulcerative colitis patients, and to investigate which patient or donor factors are responsible for the treatment success. MethodsThis is an open controlled trial of repeated faecal microbiota transplantation after antibiotic pre-treatment (FMT-group, n=17) vs antibiotic pre-treatment only (AB-group, n=10) in 27 therapy refractory ulcerative colitis patients over 90days. Faecal samples of donors and patients were analysed by 16SrRNA gene-based microbiota analysis. ResultsIn the FMT-group, 10/17 (59%) of patients showed a response and 4/17 (24%) a remission to faecal microbiota transplantation. Response to faecal microbiota transplantation was mainly influenced by the taxonomic composition of the donor's microbiota. Stool of donors with a high bacterial richness (observed species remission 94693 vs no response 797 +/- 181 at 15367rps) and a high relative abundance of Akkermansia muciniphila (3.3 +/- 3.1% vs 0.1 +/- 0.2%), unclassified Ruminococcaceae (13.8 +/- 5.0% vs 7.5 +/- 3.7%), and Ruminococcus spp. (4.9 +/- 3.5% vs 1.0 +/- 0.7%) were more likely to induce remission. In contrast antibiotic treatment alone (AB-group) was poorly tolerated, probably because of a sustained decrease of intestinal microbial richness. ConclusionsThe taxonomic composition of the donor's intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in ulcerative colitis patients. The design of specific microbial preparation might lead to new treatments for ulcerative colitis.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 50 条
  • [41] Fecal Microbiota Transplantation for Ulcerative Colitis: Dispelling the "Yuck Factor"
    Nicholson, Maribeth R.
    Kahn, Stacy A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (06): : 663 - 664
  • [42] Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis
    Uygun, Ahmet
    Ozturk, Kadir
    Demirci, Hakan
    Oger, Cem
    Avci, Ismail Yasar
    Turker, Turker
    Gulsen, Mustafa
    MEDICINE, 2017, 96 (16)
  • [43] Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
    Zhang, Xiaochen
    Ishikawa, Dai
    Nomura, Kei
    Fukuda, Naoyuki
    Haraikawa, Mayuko
    Haga, Keiichi
    Shibuya, Tomoyoshi
    Mita, Toshihiro
    Nagahara, Akihito
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [44] Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis
    D'onofrio, Antonio M.
    Ferrajoli, Gaspare F.
    Calia, Rosaria
    Oggiano, Lorenza
    Di Vincenzo, Federica
    Petito, Valentina
    Maggio, Eleonora
    Napolitano, Daniele
    Masi, Letizia
    Schiavoni, Elisa
    Fanali, Caterina
    Puca, Pierluigi
    Turchini, Laura
    Lopetuso, Loris R.
    Del Chierico, Federica
    Putignani, Lorenza
    Sani, Gabriele
    Gasbarrini, Antonio
    Scaldaferri, Franco
    Camardese, Giovanni
    MINERVA PSYCHIATRY, 2024, 65 (03): : 256 - 269
  • [45] Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis
    Ishikawa, Dai
    Sasaki, Takashi
    Osada, Taro
    Kuwahara-Arai, Kyoko
    Haga, Keiichi
    Shibuya, Tomoyoshi
    Hiramatsu, Keiichi
    Watanabe, Sumio
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (01) : 116 - 125
  • [46] DOP020 Baseline Microbiota and Differences in Donor-Recipient Richness as Determinants of Fecal Microbiota Transplantation Efficacy in Ulcerative Colitis
    Deleu, S.
    Castellanos, J. Vazquez
    Andreu-Sanchez, S.
    Caenepeel, C.
    Verstockt, S.
    Arnauts, K.
    Baert, F.
    Mana, F.
    Lobaton, T.
    Pouillon, L.
    Louis, E.
    Franchimont, D.
    Verstockt, B.
    Ferrante, M.
    Sabino, J.
    Raes, J.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i124 - i125
  • [47] Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation
    Shen, Zhao-Hua
    Zhu, Chang-Xin
    Quan, Yong-Sheng
    Yang, Zhen-Yu
    Wu, Shuai
    Luo, Wei-Wei
    Tan, Bei
    Wang, Xiao-Yan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (01) : 5 - 14
  • [48] Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study
    Sood, Ajit
    Mahajan, Ramit
    Singh, Arshdeep
    Midha, Vandana
    Mehta, Varun
    Narang, Vikram
    Singh, Tarundeep
    Pannu, Anmol Singh
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (10): : 1311 - 1317
  • [49] Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)
    Haifer, C.
    Saikal, A.
    Paramsothy, S.
    Borody, T. J.
    Ghaly, S.
    Kaakoush, N. O.
    Leong, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S029 - S029
  • [50] Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply
    Costello, S. P.
    Soo, W.
    Bryant, R. V.
    Jairath, V.
    Hart, A. L.
    Andrews, J. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (06) : 631 - 632